Ipca Laboratories’ arm picks up additional 20% share capital of Bayshore

01 Oct 2021 Evaluate

Ipca Laboratories’ wholly owned subsidiary -- Ipca Pharmaceuticals, Inc., USA has acquired further 20% share capital of Bayshore Pharmaceuticals LLC (Bayshore), a New Jersey limited liability company for $1.2 million. With this acquisition, Bayshore is now wholly owned by Ipca Pharmaceuitcals, Inc.

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in many countries and its export accounts for around half of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates.

Ipca Laboratories Share Price

1459.30 2.15 (0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×